Clinical trial

UTSW HP [13-C] Pyruvate Injection in HCM

NCT03057002

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-05-01

PhaseN/A

Study timeline

Study start (actual)2018-05-01Date precision: day

Registry last updated2025-03-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiomyopathy, Hypertrophicunresolved

Dilated Cardiomyopathyunresolved

Duchenne Muscular Dystrophyunresolved

Cardiac Sarcoidosisunresolved

Becker Muscular Dystrophyunresolved

Heart Failure With Preserved Ejection Fractionunresolved

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

Hyperpolarized 13C-PyruvateDIAGNOSTIC_TEST

Sponsors & collaborators

University of Texas Southwestern Medical Centerlead sponsor

Mapped research locations

DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03057002 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.